Debt-to-equity in % of ESSA Pharma Inc. from Q2 2021 to Q2 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
ESSA Pharma Inc. quarterly Debt-to-equity history and change rate from Q2 2021 to Q2 2025.
  • ESSA Pharma Inc. Debt-to-equity for the quarter ending 30 Jun 2025 was 2.33 %, a 17.7% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

ESSA Pharma Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q2 2025 2.33 -0.5 -17.7% 30 Jun 2025
Q1 2025 2.69 +0.03 +1.13% 31 Mar 2025
Q4 2024 3.09 +0.91 +41.9% 31 Dec 2024
Q3 2024 2.95 +0.98 +49.9% 30 Sep 2024
Q2 2024 2.83 +1.11 +64.5% 30 Jun 2024
Q1 2024 2.66 +0.88 +49.5% 31 Mar 2024
Q4 2023 2.17 +0.2 +10.1% 31 Dec 2023
Q3 2023 1.96 -0.08 -3.92% 30 Sep 2023
Q2 2023 1.72 -0.48 -21.8% 30 Jun 2023
Q1 2023 1.78 -0.3 -14.4% 31 Mar 2023
Q4 2022 1.97 -0.13 -6.19% 31 Dec 2022
Q3 2022 2.04 -0.14 -6.43% 30 Sep 2022
Q2 2022 2.21 +0.09 +4.25% 30 Jun 2022
Q1 2022 2.08 31 Mar 2022
Q4 2021 2.1 31 Dec 2021
Q3 2021 2.18 30 Sep 2021
Q2 2021 2.12 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.